The iPSYCH ASD sample is a part of a population based case-cohort sample extracted from a baseline cohort10 consisting of all children born in Denmark between May 1st 1981 and December 31st 2005. Eligible were singletons born to a known mother and resident in Denmark on their one-year birthday. Cases were identified from the Danish Psychiatric Central Research Register (DPCRR)12 (link), which includes data on all individuals treated in Denmark at psychiatric hospitals (from 1969 onwards) as well as at outpatient psychiatric clinics (from 1995 onwards). Cases were diagnosed with ASD in 2013 or earlier by a psychiatrist according to ICD10, including diagnoses of childhood autism (ICD10 code F84.0), atypical autism (F84.1), Asperger’s syndrome (F84.5), other pervasive developmental disorders (F84.8), and pervasive developmental disorder, unspecified (F84.9). As controls we selected a random sample from the set of eligible children excluding those with an ASD diagnosis by 2013.
The samples were linked using the unique personal identification number to the Danish Newborn Screening Biobank (DNSB) at Statens Serum Institute (SSI), where DNA was extracted from Guthrie cards and whole genome amplified in triplicates as described previously13 (link),97 . Genotyping was performed at the Broad Institute of Harvard and MIT (Cambridge, MA, USA) using the PsychChip array from Illumina (CA, San Diego, USA) according to the instructions of the manufacturer. Genotype calling of markers with minor allele frequency (MAF) > 0.01 was performed by merging callsets from GenCall98 and Birdseed99 while less frequent variants were called with zCall100 . Genotyping and data processing was carried out in 23 waves.
All analyses of the iPSYCH sample and joint analyses with the PGC samples were performed at the secured national GenomeDK high performance-computing cluster in Denmark.
The study was approved by the Regional Scientific Ethics Committee in Denmark and the Danish Data Protection Agency.